期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine 被引量:2
1
作者 Mohadeseh Khoshandam Hossein Soltaninejad +2 位作者 marziyeh mousazadeh Amir Ali Hamidieh Saman Hosseinkhani 《Genes & Diseases》 SCIE CSCD 2024年第1期268-282,共15页
CRISPR/Cas9 is an effective gene editing tool with broad applications for the pre-vention or treatment of numerous diseases.It depends on CRiSPR(clustered regularly inter-spaced short palindromic repeats)as a bacteria... CRISPR/Cas9 is an effective gene editing tool with broad applications for the pre-vention or treatment of numerous diseases.It depends on CRiSPR(clustered regularly inter-spaced short palindromic repeats)as a bacterial immune system and plays as a gene editing tool.Due to the higher specificity and efficiency of CRISPR/Cas9 compared to other editing ap-proaches,it has been broadly investigated to treat numerous hereditary and acquired ill-nesses,including cancers,hemolytic diseases,immunodeficiency disorders,cardiovascular diseases,visual maladies,neurodegenerative conditions,and a few X-linked disorders.CRISPR/Cas9 system has been used to treat cancers through a variety of approaches,with sta-ble gene editing techniques.Here,the applications and clinical trials of CRisPR/Cas9 in various illnesses are described.Due to its high precision and efficiency,CRISPR/Cas9 strategies may treat gene-related illnesses by deleting,inserting,modifying,or blocking the expression of specific genes.The most challenging barrier to the in vivo use of CRISPR/Cas9 like off-target effects will be discussed.The use of transfection vehicles for CRISPR/Cas9,including viral vectors(such as an Adeno-associated virus(AAV),and the development of non-viral vectors is also considered. 展开更多
关键词 Clinical trials CRISPR/Cas9 Gene therapy Non-viral vectors Viral vectors
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部